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The Neuroendocrine Protein 7B2 Is Required for
Peptide Hormone Processing In Vivo and Provides
a Novel Mechanism for Pituitary Cushing's Disease
proprotein substrates at paired basic residues to gener-
ate mature secreted or cell surface proteins and/or bio-
logically active peptides. Two of these enzymes, prohor-
mone convertases 1 and 2 (PC1/PC3 and PC2), are
principally involved in the processing of precursors of
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require interaction with the neuroendocrine protein 7B2
(Braks and Martens, 1994) in order to generate the enzy-
matically active mature form (Zhu and Lindberg, 1995;
Summary Muller et al., 1997).
Due to the widespread distribution of PC1/PC3 and
The neuroendocrine protein 7B2 has been implicated PC2 in the brain and neuroendocrine system, defects
in activation of prohormone convertase 2 (PC2), an in the expression or activity of these enzymes would be
important neuroendocrine precursor processing en- expected to produce complex disturbances of endo-
doprotease. To test this hypothesis, we created a null crine function, behavior, and metabolism. A human sub-
mutation in 7B2 employing a novel transposon-facili- ject with genetic defects in both alleles of PC1/PC3 is
tated technique and compared the phenotypes of 7B2 obese, hypocortisolic, and hypogonadal (Jackson et al.,
and PC2 nulls. 7B2 null mice have no demonstrable 1997). In contrast, PC2 null mice show no abnormalities
PC2 activity, are deficient in processing islet hor- of steroidogenesis or reproduction, although they are
mones, and display hypoglycemia, hyperproinsulin- hypoglycemic and mildly runted (Furuta et al., 1997).
emia, and hypoglucagonemia. In contrast to the PC2 The islets of PC2 null mice contain reduced numbers of
null phenotype, these mice show markedly elevated b cells and markedly increased numbers of a and d cells,
circulating ACTH and corticosterone levels, with adre- reflecting the defective processing of proglucagon to
nocortical expansion. They die before 9 weeks of se- glucagon and of somatostatin 28 to somatostatin 14.
vere Cushing's syndrome arising from pituitary inter- Proinsulin processing is less completely inhibited be-
mediate lobe ACTH hypersecretion. We conclude that cause of the coexpression of PC1/PC3 in the b cells,
7B2 is indeed required for activation of PC2 in vivo where this enzyme apparently plays a more dominant
but has additional important functions in regulating role than PC2 (Furuta et al., 1998). The hypoglycemia
pituitary hormone secretion. arising from the severe glucagon deficiency accounts
for the decreased b cell mass as a response to reduced
demand for insulin (Furuta et al., 1998).Introduction
7B2, a small acidic protein exclusively localized to
neuroendocrine tissues (Iguchi et al., 1984; Marcinkie-A wide variety of biologically active proteins and pep-
wicz et al., 1994), was first identified in 1982 by Seidahtides are generated in animal cells via proteolytic pro-
and colleagues (Hsi et al., 1982) and has since beencessing of inactive or less active precursor proteins.
extensively employed as a neuroendocrine marker (Roe-Recently, a eukaryotic family of serine proteases related
broek et al., 1989; Ohashi et al., 1990; Vieau et al., 1992;to subtilisin has been identified and shown to be in-
Collini et al., 1998). While it is now clear that 7B2 repre-volved in this processing (reviewed in Rouille et al., 1995;
sents a specific binding protein for PC2 (Braks and Mar-Seidah and Chretien, 1997). In mammals, the seven
tens, 1994; Benjannet et al., 1995a; Zhu and Lindberg,members of this novel endoprotease family are all local-
1995), the mechanism of the interaction of 7B2 with PC2ized within the secretory pathway where they cleave
is not well understood. Recent studies indicate that the
two proteins bind early in the secretory pathway (Ben-
jannet et al., 1995a; Muller et al., 1997), and binding# To whom correspondence should be addressed (e-mail: leder@
rascal.med.harvard.edu [P. L.], ilindb@lsumc.edu [I. L.]). determinants have been identified on both 7B2 (Zhu et
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al., 1996; Van Horssen and Martens, 1998) and PC2
(Benjannet et al., 1995b, 1998; Zhu et al., 1998). Matura-
tion of proPC2 to PC2, assisted by 7B2, occurs in the
later stages of the secretory pathway (reviewed in
Steiner, 1998). While the precise role of 7B2 in this pro-
cess is not known, it is clear that proPC2 molecules
which have not encountered 7B2 prior to secretion can
undergo cleavage of the propeptide without acquiring
enzymatic activity (Muller et al., 1997; Zhu et al., 1998).
An analysis of the role of 7B2 in the regulation of peptide
hormone production has been hampered by the lack of
regulated neuroendocrine cell lines that do not express
7B2.
In order to provide in vivo evidence of the link between
7B2 and PC2 activity, we generated 7B2 null mice using
a novel transposon-based technique (Westphal and
Leder, 1997). As predicted, these mice lack PC2 activity
and have multiple metabolic derangements, similar but
not identical to those found in PC2 null mice (Furuta et
al., 1997). Interestingly, in contrast to PC2 null mice, 7B2
null mice develop and die of Cushing's disease, with
multiple sequelae of hypercorticosteronism, indicating
a novel role for 7B2 in the normal control of secretion
of peptides from the intemediate lobe of the pituitary.
Results
Figure 1. Targeting Construct, Genotype, and RNA Expression
Generation of 7B2 Null Mice Using a Novel Analysis
Transposon-Based Approach (A) The targeting construct was generated using a transposon-
We have employed in vitro transposition to rapidly gen- based technique, as described previously (Westphal and Leder,
1997). Exon 3 of 7B2 (Braks et al., 1996) was interrupted by randomerate mouse knockout and knockin constructs (West-
integration of a transposon and subsequent introduction of a neophal and Leder, 1997). Using the previously described
cassette. The care of all animals used in these studies was in accor-technique, a construct was generated to target 7B2, a
dance with NIH and institutional guidelines.
gene which lies within 50 kb of the 39 end of the formin (B) Southern analysis indicates that mice of all genotypes are born
gene, previously studied in our laboratory (Wang et al., from heterozygotic matings. The mutant allele is 7.6 kb, while the
1997) (Figure 1A). Briefly, this approach is based upon WT allele is 6 kb.
(C) Northern analysis of mouse brain RNA. 7B2 null mice do notrandom in vitro integration of transposable elements
express 7B2 RNA (right two lanes). RNA was extracted from two(Devine and Boeke, 1994) and selection of rare transpo-
brains for each genotype, and a GAPDH loading control is shown.sition events that have integrated into exonic DNA. Note
that chromosomal rearrangement at the 7B2 locus upon
homologous recombination is excluded in the transpo- and 7B2 null mice. As shown in Figure 1C, 7B2 null mice
lack detectable 7B2 RNA transcripts.son-based approach, since the integrity of this site is
verified by probing both the 59 and 39 ends (Westphal
and Leder, 1997). 7B2 Null Mice Are Deficient in proPC2 Protein
Maturation and Devoid of PC2 ActivityAfter electroporation of the gene-targeting construct
into embryonic stem cells (Meiner et al., 1996), several Initial demonstrations that the 7B2 and PC2 proteins
interact (Braks and Martens, 1994) were followed byES clones were shown to have undergone homologous
recombination (Westphal and Leder, 1997). Two inde- studies which indicated that PC2 activity may be totally
dependent upon 7B2 expression (Zhu and Lindberg,pendent targeted ES clones were injected into blasto-
cysts, chimeric mice were derived, and germline trans- 1995). We were hence interested to see how PC2 levels
and activity might be affected by loss of 7B2 functionmission was achieved (data not shown). Subsequent
matings of chimeric 129 SvEv males to SvEv females in vivo. In an initial analysis of PC2 protein expression
in brain (where PC2 is expressed at high levels), wild-allowed us to place the targeted allele on a pure genetic
background. All mice presented in this study were de- type and null brains were homogenized and then sepa-
rated by SDS-PAGE and probed with anti-PC2 antise-rived from two independent ES clones, and no difference
was noticed between the two independent mouse lines. rum. In three independent experiments, the maturation
of proPC2 was severely inhibited in 7B2 null mice (FigureIn addition, 7B2 null mice were generated in both 129/
FVB and 129/Bl6 mixed backgrounds, with identical 2A, right lane). In order to examine the catalytic ability
of PC2 in 7B2 null mice, we immunopurified PC2 fromphenotypes observed in each background (data not
shown). Genotyping of heterozygotic matings indicated detergent extracts of wild-type and null mouse brains
with anti-PC2 antibodies and performed fluorometricoffspring of all possible genotypes (Figure 1B). In order
to analyze 7B2 RNA levels, whole brains were extracted PC2 activity assays (Figure 2B; each line represents
three independent determinations per genotype). Ourand Northern blots were prepared from 7B2 wild-type
Lethal Cushing's Disease in the 7B2 Null Mouse
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Figure 2. ProPC2 Is Incompletely Processed
and Is Enzymatically Inactive in 7B2 Null An-
imals
(A) Western blot of proPC2/PC2 forms in the
brains of wild-type or null animals. The matu-
ration of proPC2 (upper band) to PC2 (lower
band) is significantly impaired in mutant ani-
mals (right).
(B) Enzymatic activity of PC2 immunopurified
from the brains of wild-type (solid circles) or
7B2 null mice (open circles) was assayed
against a fluorogenic peptide substrate, as
described in Experimental Procedures. Spec-
ificity of the PC2 assay was verified by as-
sessing inhibition using the PC2 inhibitor CT
peptide 1±31 at 1 mM.
results indicate that 7B2 null mice completely lack PC2 several PC2-dependent polypeptide hormones. In order
to study proglucagon processing, pancreatic islets wereactivity (Figure 2B), confirming a physiological require-
ment for 7B2 in PC2 activation (Zhu and Lindberg, 1995). pulse±chase labeled, and immunoprecipitated gluca-
gon-related proteins were subjected to SDS-PAGE. As
shown in Figure 3A, the generation of mature glucagonImmature Glucagon and Insulin and Decreased
Enkephalins in 7B2 Null Mice is essentially eliminated in 7B2 null islets and only small
amounts of intermediate cleavage products are gener-Since 7B2 null mice exhibited metabolic derangements
and lacked PC2 activity, we assessed the production of ated, in contrast to the rapid and complete conversion
Figure 3. PC2-Dependent Processing Is Dis-
rupted in 7B2 Null Mice
(A) Proglucagon processing. Islets were la-
beled for 45 min and chase incubated for 1
hr and 3 hr, respectively, as described in Ex-
perimental Procedures. Note marked reduc-
tion in processing of proglucagon to gluca-
gon in 7B2 null islets. Similar results were
obtained in at least two other independent
experiments. Immunoprecipitated glucagon-
related peptides were analyzed by gradient
SDS-PAGE. Glucagon, proglucagon 33±61;
Glicentin, proglucagon 1±69; GRPP-Glu, gli-
centin-related polypeptide-glucagon, proglu-
cagon 1±61; P, pulsed cells; 1C and 3C,
chased cells of 1 hr and 3 hr, respectively;
M, combined chase media.
(B) Proinsulin processing. Islets were labeled
for 45 min and chase incubated for 1 hr as
in (A). Note the rapid conversion of mouse
proinsulin I and II into insulin in the wild-type
islets and the slower conversion in the 7B2
null islets associated with significant accu-
mulations of des-31,32 intermediates (peaks
c and d). Immunopurified insulin-related pep-
tides were resolved by HPLC. Peaks are as
follows (based upon assignments given in
Figure 1 of Furuta et al., 1998): a, mouse insu-
lin II; b, mouse insulin I; c, des-31,32 mouse
proinsulin II; d, des-31,32 mouse proinsulin I;
g, mouse proinsulin II; h, mouse proinsulin I.
(C) Analysis of immunoreactive enkephalins
in acid extracts prepared from 7B2 null (open
circles) or wild-type (solid circles) mouse
brains. Note the significant reduction of Met-
enk-Arg-Phe and complete absence of Met-
enkephalin in 7B2 null mouse brain.
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to glucagon in wild-type islets (Furuta et al., 1997). Simi- pituitary/adrenal axis leading to elevated blood steroid
larly, pancreatic islets were labeled in order to analyze levels. As a first step in investigating this possibility, we
insulin maturation. In wild-type islets (Figure 3B, left measured total pituitary ACTH in wild-type and 7B2 null
panel), mouse proinsulin I and II are rapidly converted animals and found a 10- to 20-fold elevation of intact
to insulin; in contrast, this conversion is significantly ACTH, with none of the ACTH cleavage product CLIP
delayed in null islets accompanied by the generation of (corticotropin-like intermediate peptide) detected in 7B2
increased amounts of des 31,32 proinsulin intermediate null animals (Figure 5A). Similar results were seen in
material (peaks c and d in Figure 3B, right lower panel). three other experiments. In agreement, biosynthetic
This intermediate of proinsulin is produced by PC1/PC3, studies of POMC processing in isolated whole pituitaries
which exhibits a cleavage preference for the B chain±C showed markedly elevated production of intact ACTH
peptide junction, and it also accumulates in PC2 null and minimal conversion of this peptide to a melanocyte-
mice (Furuta et al., 1998). Since the production of mature stimulating hormone (a-MSH), a processing event nor-
enkephalins is known to be dependent upon PC2 activity mally mediated by PC2 in the intermediate lobe (Zhou
(Johanning et al., 1996), we also analyzed these peptides et al., 1993) (Figure 5B). Immunohistochemical studies
in wild-type and 7B2 null mouse brains. The levels of showed marked reduction in anterior lobe staining for
two mature enkephalins are dramatically reduced in null ACTH in 7B2 nulls (Figure 5C, lower panels). In the inter-
brains (left and right panels, Figure 3C). This result is mediate lobe, cross-reaction of the ACTH antiserum
consistent with measurements of proenkephalin-derived with the PC2-mediated cleavage product CLIP (see Fig-
products in PC2 null brain (Johanning et al., 1998). In ure 5A) would be expected to obscure differences be-
sum, these data indicate that the lack of PC2 activity tween the 7B2 null and control mice. Alterations in ACTH
seen in 7B2 null mice leads to significantly reduced processing are best detected using an antiserum to the
tissue levels of mature glucagon, insulin, and enkeph- amidated cleavage product a-MSH, which (by virtue of
alins. being amide specific) does not react with intact ACTH.
Figure 5C (upper panels) shows that the intermediate
7B2 Mutant Mice Manifest Severe lobe of the 7B2 null exhibits markedly reduced a-MSH
Metabolic Abnormalities staining compared to wild-type intermediate lobe. These
Since PC2 null mice are hypoglycemic due to lack of data confirm the lack of ACTH cleavage detected in the
mature glucagon, showing some increase in proinsulin
biosynthetic studies, and, taken together with radioim-
levels (Furuta et al., 1997), we analyzed 7B2 null mouse
munoassay data demonstrating high levels of intact
blood samples for insulin and sugar levels. At 4±5 weeks
ACTH in the intermediate lobe of the 7B2 null (unpub-of age, 7B2 null mice are severely runted, hypoglycemic,
lished observations), confirm that the increase in totaland have elevated circulating insulin-like material (Fig-
pituitary ACTH seen in the 7B2 null pituitary residesure 4A). Clear clinical signs of abnormality are apparent
solely in the intermediate lobe.in these animals even at 4 days of age. Figure 4B depicts
Consistent with the increased pituitary levels of ACTH,two 7B2 null mice flanked by two littermate wild-type
circulating ACTH in plasma obtained from 7B2 null ani-mice; the null mice are pale and ecchymotic (note espe-
mals was greatly elevated over controls (Figure 6A; thecially the severe bruising of the left null). Many 7B2 null
animal to animal variation is most likely due to stress inmice suffer from significant bleeding into the abdomen,
handling). We therefore assayed serum corticosteroneleading to their pale appearance (data not shown). In
in 7B2 null and wild-type mice. As expected, serumfact, only 11% of mutant mice survive to weaning (i.e.,
corticosterone was elevated approximately 4-fold in 7B2we obtained 12 nulls in a total of 109 offspring of hetero-
mutant mice (Figure 6A). Given the raised levels of ste-zygotic matings at weaning). Despite initial runting, how-
roids, the pathology of the adrenal cortex was examined.ever, those null mice that survive to weaning show ab-
In agreement with the known trophic influence of ACTHnormal fat deposition, especially on the back and around
on the adrenal cortex, 7B2 null mice exhibit corticalthe neck.
hyperplasia compared to age-matched controls (FigureThe observed defects in sugar and fat metabolism in
6B). The presence of high plasma ACTH and steroidsthe 7B2 null mice prompted us to study the pancreas
coupled with cortical hyperplasia supports a diagnosisin greater detail. As shown in Figure 4C, both b and
of Cushing's syndrome in these animals.non±b endocrine cell mass are significantly expanded
in the pancreas of 7B2 null mice, as measured by mor-
phometric analysis. These differences are demonstrated
Multiple Histologic Signs of Hypercorticosteronismin a representative manner in Figure 4D, a 1503 magnifi-
Several other clinical symptoms exhibited by the 7B2cation of a pathological specimen from a 7B2 null com-
null animal are also consistent with severe Cushing'spared to a wild-type mouse at 5 weeks of age, which
syndrome. These include changes in skin; compared toindicates both enlarged and abnormal islets. Note that
samples derived from wild-type mice, 7B2 null micethe mutant islets are hyperplastic, and also show disor-
exhibit marked thinning of the skin and dermal atrophydered architecture, with disruption of the normal eccen-
with hyperkeratosis (Figure 7, compare [A] and [B]). Eventric location of non±b cells (stained brown in both wild-
more strikingly, 7B2 null liver is markedly abnormal, withtype and mutant sections).
destruction of the normal liver architecture and severe
fat vacuolation (Figures 7C and 7D). 7B2 null spleen is7B2 Mutant Mice Develop a Novel Form
roughly one-fifth the size of wild-type spleen, with loss ofof Pituitary Cushing's Disease
normal architecture and generalized lymphoid atrophyGiven the abnormal pattern of fat deposition observed
in 7B2 null animals, we suspected a problem with the (Figures 7E and 7F). Lastly, the development of a typical
Lethal Cushing's Disease in the 7B2 Null Mouse
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Figure 4. Metabolic Parameters, Appearance,
and Generalized Islet Hyperplasia in 7B2 Null
Mice
(A) 7B2 null mice are runted, hypoglycemic,
and hyperproinsulinemic. Average values are
indicated; n 5 6 mice for each genotype
(4- to 5-week-old mice).
(B) Appearance of 7B2 null mice at 4 days of
age. Two 7B2 null mice (center) are pale and
have significant bruising when compared to
WT littermate controls (outside two mice).
(C) Morphometric analysis reveals hyperpla-
sia of both b and non±b cell mass in islets of
7B2 null mice (performed as previously de-
scribed; Withers et al., 1998). Mice were 4±5
weeks of age.
(D) Magnification (1503) of WT versus mutant
pancreatic tissue reveals generalized islet hy-
perplasia and abnormal morphology in 7B2
null mice. Islets are enlarged, with disordered
appearance of the normally eccentrically lo-
cated non±b cells (stained brown).
dorsal cervical ªbuffalo humpº of fat, a classic symptom completely lacks PC2 activity, providing in vivo confir-
of Cushing's syndrome in humans, is clearly visible in mation of the link between PC2 activation and 7B2 ex-
the null animals at 7 weeks (Figures 7G and 7H). All of pression (Zhu and Lindberg, 1995). In general agreement
these features are characteristic of full-blown Cushing's with a previously reported PC2 null mouse (Furuta et
syndrome. al., 1997), the 7B2 null mouse is hypoglycemic and hy-
perproinsulinemic, with generalized islet cell expansion
and altered islet cell morphology. The islet cell changesDiscussion
differ from those in the PC2 null mouse in that b cell
mass is also increased, possibly indicative of directWe report here the generation and characterization of
stimulation by elevated circulating corticosterone (see7B2 null mice produced using a transposon-based tech-
nique (Westphal and Leder, 1997). The 7B2 null mouse below) or an indirect effect of steroid-induced insulin
Cell
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Figure 5. Pituitary Cushing's Disease in 7B2 Null Mice: Increased ACTH in the Intermediate Lobe
(A) Radioimmunoassay of ACTH-immunoreactive peptides in pituitaries of wild-type (solid circles) or 7B2 null (open circles) mice. Note both
the dramatic increase in ACTH and absence of CLIP in 7B2 null mice.
(B) Biosynthetic processing of POMC in pituitaries. Note increased ACTH and markedly reduced a-MSH in 7B2 null pituitaries. Pituitaries from
wild-type and 7B2 mutant mice were labeled as described in Experimental Procedures. Samples were immunoprecipitated with anti-ACTH
antiserum and size separated using an SDS-PAGE tube gel system. Samples from wild-type (closed circles) and null (open circles) mice are
shown. (Top) pulse-labeled pituitaries; (middle) tissues chased in unlabeled medium; (lower) chase media. The two fractions of ACTH represent
glycosylated and nonglycosylated ACTH, respectively. Similar results were seen in three independent experiments. A diagram of POMC
processing is shown at the top of the figure (JP, joining peptide; ACTH, adrenocorticotropic hormone; MSH, melanocyte-stimulating hormone;
CLIP, corticotropin-like intermediate peptide).
(C) ACTH and a-MSH staining in pituitary lobes. a-MSH staining is greatly reduced in the 7B2 null intermediate lobe compared to control
(upper panels). Corticotroph staining for ACTH in the anterior pituitary is shown in the lower two panels; note the complete lack of ACTH
staining in the 7B2 null as compared to wild-type anterior pituitary. Note strong ACTH/CLIP staining in the intermediate lobe of the 7B2 null;
controls are similar (data not shown). Magnification: 1003 for (A) and (B), 1503 for (C) and (D). A, anterior lobe; I, intermediate lobe.
resistance. Like the PC2 null, the 7B2 null mouse also 1991; Thomas et al., 1991; Zhou et al., 1993). However, in
the intermediate lobe, which expresses high levels ofshows severely depressed levels of bioactive peptides
such as mature enkephalins and glucagon, known to be PC2 (Day et al., 1992), this enzyme normally acts to
internally cleave ACTH into the noncorticotropic pep-synthesized by PC2-specific mechanisms (Rouille et al.,
1994, 1997; Johanning et al., 1998). However, the most tides a-MSH and CLIP (Benjannet et al., 1991; Thomas
et al., 1991; Zhou et al., 1993). In the 7B2 null pituitary,important derangement of PC2-mediated peptide pro-
cessing in the 7B2 nulls involves the synthesis of the which lacks functional PC2, this cleavage event is se-
verely impaired and intermediate lobe ACTH (generatedcorticotropin ACTH.
Both the anterior as well as the intermediate lobes of by PC1/PC3 from POMC) remains intact, resulting in
extremely high levels of ACTH in this lobe. Preliminarythe pituitary synthesize the ACTH precursor POMC. In
the anterior lobe, cleavage of POMC into full-length experiments in which intact ACTH was specifically mea-
sured by a two-site immunoassay in separate pituitaryACTHÐthe end product in this lobeÐshould be unaf-
fected by deletion of either PC2 or 7B2, since this cleav- lobes of 7B2 nulls and littermate controls confirm that
the high levels of intact ACTH normally found in theage occurs primarily through the action of PC1/PC3
rather than PC2 (Benjannet et al., 1991; Bloomquist et al., anterior lobe are instead located in the intermediate
Lethal Cushing's Disease in the 7B2 Null Mouse
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Figure 6. Pituitary Cushing's Syndrome in
7B2 Null Animals: Increased Circulating Glu-
cocorticoids Derive from Adrenal Hyperplasia
Resulting from Greatly Elevated Plasma
ACTH
(A) Plasma levels of ACTH and corticosterone
are greatly elevated in 7B2 null mice.
(B) 7B2 null mice (right) manifest a markedly
expanded adrenal cortex (marked C) when
compared to 7B2 WT mice (left). Magnifica-
tion, 203.
lobe in the 7B2 nulls (unpublished results). The PC2 null al., 1989). Although in the normal mouse maintenance
of plasma levels of ACTH is largely a function of anteriorpituitary also contains elevated levels of intact ACTH
compared to controls (unpublished data); this increase lobe secretory activity, in the 7B2 and PC2 null animals,
plasma levels might be expected to reflect secretionis presumably also due to loss of PC2 activity in the
intermediate lobe, although this has not yet been directly from both the anterior and intermediate lobes. In fact,
the elevated circulating corticosterone in the 7B2 nullsdemonstrated.
Surprisingly, the 7B2 null animals contrast sharply acts to suppress hypothalamic secretion of CRH and
anterior lobe synthesis of POMC, since POMC synthesiswith the PC2 nulls in that they exhibit high levels of
plasma ACTH and go on to develop severe pituitary is highly responsive to transcriptional inhibition by ste-
roids in the anterior but not in the intermediate lobeCushing's disease, surviving at most to 9 weeks after
birth. The adrenal cortical hyperplasia observed in these (reviewed in Autelitano et al., 1989). Consistent with this
interpretation, our data show that ACTH staining is ab-animals, a consequence of continuous trophic stimula-
tion by increased circulating ACTH, results in high serum sent, and POMC mRNA is undetectable, in the anterior
lobe of the 7B2 null (Figure 5; B. Peng and J.E. Pintar,levels of corticosterone. Elevated levels of circulating
steroids are then responsible for a number of phenotypic unpublished results). Coupled with the radioimmunoas-
say data showing increased intact ACTH in the interme-changes observed in the 7B2 null, such as atrophic skin,
lipodystrophy, and splenic lymphoid atrophy. The runt- diate lobe, these data implicate the intermediate lobe
as the sole source for the increased circulating ACTHing of 7B2 mutant pups may also be due to chronically
increased circulating corticosterone. None of these in the 7B2 null. Indeed, plasma levels of ACTH in the
PC2 mutant might also be expected to be increased,changes are observed in PC2 null mice, which exhibit
no detectable dysfunction of the pituitary/adrenal axis. since ACTH secretion probably continues from the ante-
rior as well as from the intermediate lobe. Intriguingly,These data imply that profound differences exist in the
release of pituitary peptide hormones in the two null however, the PC2 null animal shows no signs of in-
creased circulating ACTH, and corticosterone levels areanimals.
The release of ACTH from anterior lobe corticotrophs within the normal range (M. Furuta, unpublished data).
These data indicate that the 7B2 null animal exhibitsis predominantly controlled by hypothalamic corticotro-
pin-releasing hormone (CRH), while the secretion of essential differences from both wild-type and PC2 null
animals in the control of intermediate lobe pituitary se-POMC products from the intermediate lobeÐdensely
innervated by neurons arising from the basolateral hypo- cretion. Differential findings in the 7B2 as opposed to
the PC2 mutant mice point to important additional func-thalamusÐis under the influence of neurotransmitters
such as dopamine and GABA (reviewed in Autelitano et tional roles for 7B2 not related to PC2-mediated effects.
Cell
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Figure 7. Abnormal Skin, Liver, and Spleen
Morphology in 7B2 Null Mice
(A and B) 7B2 null mouse skin (B) is atrophic,
hyperkeratotic, and shows marked epidermal
thinning when compared to wild type (A).
Magnification, 203.
(C and D) 7B2 null liver lacks lobular architec-
ture and shows fat vacuolation (D) as com-
pared to wild type (C). Magnification, 203.
(E and F) Splenic lymphoid atrophy in 7B2 null
(F) versus wild-type spleen (E). Magnification,
53.
(G and H) Typical Cushingoid ªbuffalo humpº
of fat in 7B2 null (right) as opposed to wild-
type (left).
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The hypothesis of additional roles for 7B2 is strength- culminate in the exceptionally high circulating ACTH
ened by recent findings that 7B2 is found in brain areas levels in this animal. In support of this idea, preliminary
lacking PC2, while the converse has never been ob- results indicate that basal release of intact ACTH is
served (Seidel et al., 1998). With respect to the increased greatly enhanced in isolated pituitaries of 7B2 null ani-
secretion of ACTH from the pituitary of 7B2 null animals, mals compared to controls (unpublished results), sug-
these novel effects of 7B2 might be due to develop- gesting that isolated pituitaries retain the property of
mental changes during maturation of the intermediate hypersecretion even when removed from direct dopa-
lobe affecting the number and size of melanotrophs; minergic influence. Further study of the synthesis, secre-
changes in the innervation of this lobe affecting secre- tion, and regulatory roles of 7B2 in pituitary cells may
tory activity; or to effects of 7B2 on the secretory activity provide clues as to novel controlling mechanisms for
of melanotrophs. peptide hormone secretion.
Developmental proliferation and differentiation of the Cushing's disease in humans results from excessive
various pituitary cell types are known to be under the trophic stimulation of the adrenal cortex by increased
control of transcription factors such as Pit-1 (reviewed plasma ACTH (Meier and Biller, 1997). Clinically, most
in Rosenfeld et al., 1996); growth factors (Borrelli et al., pituitary adenomas expressing ACTH are found within
1992; McAndrew et al., 1995); and oncogenes such as the anterior lobe, though involvement of the intermediate
Rb (Hu et al., 1994). In the anterior lobe, maturation lobe, thought to be vestigial in humans, has been pro-
and proliferation of corticotrophs are at least in part posed (Lamberts et al., 1980). Genetic models for pitu-
controlled by hypothalamic CRH and are normally feed- itary Cushing's syndrome include the D2 receptor null
back inhibited by circulating corticosterone (reviewed cited above (Saiardi and Borrelli, 1998) and the CRH
in Autelitano et al., 1989). On the other hand, in the transgenic mouse (Stenzel-Poore et al., 1992). Interest-
intermediate lobe, highly innervated by dopaminergic ingly, despite presenting qualitatively similar steroid-
fibers, dopamine plays an important role in regulating induced tissue changes as the 7B2 null, the CRH
the proliferation of intermediate lobe melanocytes. The transgenic mouse and the D2 receptor null mouse both
D2 receptor blocker haloperidol increases the number exhibit a much less severe Cushing's phenotype, with
of melanocytes, thereby causing intermediate lobe hy- normal life spans. These data highlight the fact that loss
perplasia, while bromocriptine and other D2 receptor of 7B2 expression affects pituitary secretory activity in
agonists produce opposite effects (Chronwall et al., a much more profound manner than loss of CRH regula-
1987; reviewed in Autelitano et al., 1989). In agreement tion, dopamine receptors, or PC2. A detailed study of
with the notion of dopaminergic control of intermediate pituitary development and function in the 7B2 null
lobe growth, a recent report has shown that 4- to mouse should further our understanding of the control
6-month-old D2 receptor null mice exhibit mild interme- of ACTH and a-MSH secretion, and it may shed light
diate lobe hyperplasia and increased plasma ACTH, re-
upon the pathogenesis of some forms of Cushing's syn-
sulting in a partial Cushing's phenotype (Saiardi and
dromeÐand potentially of other diseases of secretory
Borrelli, 1998; see also Kelly et al., 1997). Alterations
hormone productionÐin humans.in pituitary morphology are also seen in the dopamine
transporter mutant mouse, which exhibits anterior and
Experimental Proceduresintermediate lobe hypoplasia (Bosse et al., 1997). The
D2 receptor null animal also exhibits significant upregu- Generation of Mice
lation of PC1 and PC2 expression, most likely due to Mice were generated by ES targeting technology, using a transpo-
both the hyperplastic changes as well as to the known son-based system to make the targeting construct, and were geno-
typed as described previously (Devine and Boeke, 1994; Westphaltranscriptional upregulation of these enzymes by dopa-
and Leder, 1997). Whole RNA was extracted from mouse brains,minergic antagonists (Bloomquist et al., 1991; Day et
and Northerns were probed with an exon 2 probe (Braks et al, 1996).al., 1992; Oyarce et al., 1996), which receptor blockade
would be expected to mimic. However, we have not
Corticosterone Assaysbeen able to demonstrate either significant intermediate
Corticosterone assays, performed on serum obtained from 5- to
lobe hyperplasia or elevated levels of either PC1 or PC2 6-week-old animals by retroorbital puncture, were carried out as
in the 7B2 null pituitary. described previously (Meiner et al., 1996). Animals were housed
Hypersecretion from the intermediate lobe constitutes together, and blood samples were taken between 10 am and 12 pm.
the most likely mechanism for the elevated plasma
Plasma ACTH, Glucose, and Insulin AssaysACTH observed in the 7B2 null animal. Secretion from
EDTA plasma was prepared from blood obtained from 5- to 6-week-this lobe is controlled by dopaminergic and GABAergic
old animals; 10 and 30 ml of 7B2 null plasma and 30 ml of WT controlinnervation. The increase in plasma ACTH resulting from
plasma (nonlittermate) were assayed in duplicate using the Nichollsintermediate lobe hyperplasia seen in the dopamine re- human ACTH 1-39 assay kit (San Juan Capistrano, CA), which is
ceptor null animal (Saiardi and Borrelli, 1998) indicates specific for intact ACTH 1-39. For glucose analyses, 4- to 5-week-
that intact ACTH can be secreted from the intermediate old mice were weighed and blood was analyzed using a standard
lobe. In agreement with this notion, intact ACTH is also glucometer. Plasma insulin levels were measured using a Linco RIA
kit (St. Charles, MO) that does not distinguish between insulin andelevated in plasma in an equine Cushing's syndrome
proinsulin. Animals were housed together, and blood samples weremodel in which tumors derive from the intermediate lobe
taken between 10 am and 12 pm (glucose and insulin) or 1 and 3(Orth and Nicholson, 1982). However, the lack of severe
pm (ACTH).
Cushing's syndrome in the dopamine receptor and
transporter nulls implies that while developmental alter- Pathology and Pancreatic Morphometry
ations in dopaminergic innervation can potentially con- Tissues from mice between 5±6 weeks of age were removed and
tribute to the pathogenesis of this disease, other secre- fixed in Optimal Fix (American Histology Reagent, Lodi, CA), blocked
in paraffin, sectioned at 10 mm, and stained with hematoxylin andtory deficits must also be present in the 7B2 null which
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eosin. Pancreatic tissue was excised, fixed in Bouin's solution, and coupled to Bio-Rad Affi-Gel 10 agarose beads. Insulin and proinsu-
lin-related proteins were eluted from the beads and separated byembedded in paraffin. Sections (5±7 mm) were immunoperoxidase
labeled for the non±b cell hormones using a cocktail of antibodies HPLC as described (Furuta et al., 1998).
and counterstained with hematoxylin. b and non±b endocrine mass
were quantitated by point-counting morphometry as described pre-
Pituitary ACTH Analysisviously (Withers et al., 1998).
Pituitaries from three 7B2 null and three wild-type mice were individ-
ually homogenized via sonication in 150 ml ice-cold 1 N acetic acid.PC2 Western Blotting
The samples were stored frozen at 2708C prior to thawing. TheBrains were homogenized in 2 ml of boiling Laemmli sample buffer
samples were subjected to centrifugation for 10 min at 13,000 rpmcontaining 6 M urea for 5 min. Proteins were then separated by SDS-
in a microfuge at 48C. The clear supernatants were transferred toPAGE on 8.8% gels. Immunoblotting was performed as described
new tubes. One hundred microliter aliquots of each sample werepreviously, employing antiserum directed against PC2 carboxyl ter-
sequentially injected onto a high-pressure gel permeation chroma-minus (Muller et al., 1997). In a parallel experiment, brains were
tography column array consisting of two 250 mm 3 5 mm TSK-250homogenized in 2 ml of 0.1 N HCl, frozen at 2808C, thawed, and
columns preceded by a guard column (Johanning et al., 1996). Thebriefly sonicated. Precipitated proteins were pelleted at 10,000 g
eluant was 32% acetonitrile, 0.1% trifluoroacetic acid, and the flowfor 20 min at 48C. Pellets were solubilized in boiling Laemmli sample
rate was 0.5 ml/min. Fifty 1 min samples were collected. BSA (100buffer before separation of proteins by SDS-PAGE and immunoblot-
mg) was immediately added to each as a carrier protein, and theting. Both extraction procedures yielded identical results.
samples were stored frozen prior to analysis by radioimmunoassay
(RIA). Fifteen microliters of each fraction was subjected in duplicatePC2 Enzyme Assay
to RIA for ACTH-immunoreactive peptides. The polyclonal anti-Brains were homogenized on ice in 50 mM Tris-HCl (pH 7.5), con-
ACTH antiserum DP5 was raised against residues 1±39 of humantaining 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1
ACTH (gift of Dr. Peng Loh, NIH, Washington, D.C.) (Castro et al.,mM EDTA, and protease inhibitors (1 mM pepstatin, 1 mM trans-
1989) and was used at a final dilution of 1:24,000. Results depictepoxysuccinic acid, 280 mM tosylphenylalanine chloromethyl ke-
total immunoreactive ACTH per HPGPC fraction for one control andtone, 140 mM tosylysyl chloromethyl ketone, and 1 mM phenylmeth-
one 7B2 null pituitary. The entire experiment was repeated threeanesulfonyl fluoride). The homogenate was centrifuged at 15,000 3
times with different sets of pituitaries with similar results.g for 20 min at 48C, and the supernatant was collected. The brain
extracts were incubated for 3±4 hr with 75 ml of 50% anti-PC2 IgG-
coupled protein A-Sepharose. Antisera used were either directed Pituitary Immunocytochemistry
against the carboxyl terminus of PC2 (Zhu and Lindberg, 1995) or Pituitiaries from wild-type and null animals were removed, fixed in
were preimmune (results not shown). Immunopurified PC2 was formaldehyde, embedded in paraffin, and sectioned at 5 mm. A
washed once with the extraction buffer and twice with PBS. The standard immunohistochemistry protocol using an avidin-biotin
beads were then resuspended to a 25% solution in PBS. PC2 activity complex kit from Pierce was then followed; alkaline phosphatase
was measured in 20 ml of this solution as previously described was used to visualize the complex. The primary antibodies were
(Lindberg et al., 1995). Briefly, the assay was performed in 100 mM ACTH C-terminal-specific antiserum Kathy, used at a final dilution
sodium acetate (pH 5.0), containing 5 mM CaCl2, 0.1% Brij, and of 1:200,000 (Schnabel et al., 1989); and a-MSH antiserum Wanda,
protease inhibitors (1 mM pepstatin, 1 mM trans-epoxysuccinic acid, used at 1:50,000 (gifts of R. E. Mains, Johns Hopkins University
280 mM tosylphenylalanine chloromethyl ketone, and 140 mM tosyly- School of Medicine, Baltimore, MD).
syl chloromethyl ketone). The 7B2 carboxy-terminal domain (CT
peptide), a PC2-specific inhibitor (Lindberg et al., 1995), was added
at 1 mM final concentration in some experiments. The incubations Pituitary Biosynthetic Labeling and Analysis
were conducted at 378C in the presence of Pyr-Glu-Arg-Thr-Lys- of POMC-Derived Peptides
Arg-methylcoumarinamide (MCA) as a substrate. Fluorescence of Immediately after decapitation of mice, pituitaries were removed
released aminomethylcoumarin (AMC) was measured with a Cam- and rinsed with 20 vol of serum-free DMEM medium without methio-
bridge Technology fluorometer (Cambridge, MA), and the amount nine (starvation medium) containing 2 mg/ml FAF-BSA. The tissues
of released AMC was calculated by reference to a free AMC stan- were then labeled with 35S-methionine (2 mCi/ml in starvation me-
dard. PC2 activity was measured on triplicates. Results are the dium, Amersham, 1000 Ci/mmol) for 3 hr, followed by another 3
mean of brains from three wild-type and three null mice 6 standard hr chase incubation in medium supplemented with nonradioactive
deviation. methionine. To ensure a continuous supply of 35S-methionine during
the pulse labeling period, the labeling medium was replaced once.
Pulse±Chase Analysis of Islet Glucagon Pituitary tissues were extracted with 5 N acetic acid containing 2
and Insulin Biosynthesis mg/ml FAF-BSA, frozen and thawed three times, and sonicated.
Islets of Langerhans were isolated, cultured overnight in RPMI me- After brief centrifugation, the supernatants were lyophilized and
dium containing 11 mM glucose and 10% fetal calf serum, and then resuspended in LIB buffer. Chase media were diluted with the same
pulse-labeled for 45 min at 378C in groups of 300±400 islets in buffer. POMC-related peptides were immunoprecipitated with an
medium containing 27.7 mM glucose and 500 mCi each of 35S-methi- antiserum against the N-terminal residues of ACTH (gift of Dr. Dick
onine (1,000 Ci/mmol) and 3H-leucine (300 mCi/mmol) (Amersham Mains, Johns Hopkins) and protein A-Sepharose. Immunoprecipi-
Corp.), as described previously (Furuta et al., 1998). The islets were tated materials were separated on SDS-PAGE tube gels, sliced, and
then washed and transferred in groups to chase medium (Furuta radioactivity in each slice estimated by scintillation counting.
et al., 1998) containing 5 mM glucose and 20 mg/ml of unlabeled
methionine and leucine and incubated at 378C for periods of 1, 2,
and 3 hr. Labeled islets were frozen and thawed three times and Acknowledgments
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